Haemonetics Other Long-Term Assets 2010-2024 | HAE
Haemonetics other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Haemonetics Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $136 |
| 2023 | $107 |
| 2022 | $63 |
| 2021 | $71 |
| 2020 | $62 |
| 2019 | $12 |
| 2018 | $12 |
| 2017 | $12 |
| 2016 | $14 |
| 2015 | $11 |
| 2014 | $11 |
| 2013 | $11 |
| 2012 | $11 |
| 2011 | $10 |
| 2010 | $10 |
| 2009 | $5 |
| Haemonetics Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $160 |
| 2024-09-30 | $156 |
| 2024-06-30 | $142 |
| 2024-03-31 | $136 |
| 2023-12-31 | $127 |
| 2023-09-30 | $117 |
| 2023-06-30 | $117 |
| 2023-03-31 | $107 |
| 2022-12-31 | $103 |
| 2022-09-30 | $80 |
| 2022-06-30 | $71 |
| 2022-03-31 | $63 |
| 2021-12-31 | $65 |
| 2021-09-30 | $67 |
| 2021-06-30 | $69 |
| 2021-03-31 | $71 |
| 2020-12-31 | $70 |
| 2020-09-30 | $71 |
| 2020-06-30 | $72 |
| 2020-03-31 | $62 |
| 2019-12-31 | $64 |
| 2019-09-30 | $30 |
| 2019-06-30 | $31 |
| 2019-03-31 | $12 |
| 2018-12-31 | $11 |
| 2018-09-30 | $12 |
| 2018-06-30 | $11 |
| 2018-03-31 | $12 |
| 2017-12-31 | $12 |
| 2017-09-30 | $13 |
| 2017-06-30 | $13 |
| 2017-03-31 | $12 |
| 2016-12-31 | $14 |
| 2016-09-30 | $14 |
| 2016-06-30 | $14 |
| 2016-03-31 | $14 |
| 2015-12-31 | $15 |
| 2015-09-30 | $16 |
| 2015-06-30 | $11 |
| 2015-03-31 | $11 |
| 2014-12-31 | $14 |
| 2014-09-30 | $11 |
| 2014-06-30 | $10 |
| 2014-03-31 | $11 |
| 2013-12-31 | $10 |
| 2013-09-30 | $13 |
| 2013-06-30 | $11 |
| 2013-03-31 | $11 |
| 2012-12-31 | $17 |
| 2012-09-30 | $17 |
| 2012-06-30 | $11 |
| 2012-03-31 | $11 |
| 2011-12-31 | $10 |
| 2011-09-30 | $10 |
| 2011-06-30 | $10 |
| 2011-03-31 | $10 |
| 2010-12-31 | $9 |
| 2010-09-30 | $10 |
| 2010-06-30 | $9 |
| 2010-03-31 | $10 |
| 2009-12-31 | $6 |
| 2009-09-30 | $6 |
| 2009-06-30 | $5 |
| 2009-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $3.164B | $1.309B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||